Boston Scientific Corporation

Boston Scientific Corporation today announced that it has been notified by the U.S. Food and Drug Administration that all issues cited in the Company's corporate wa...

Boston Scientific Corporation today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its...

Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of two spinal cord stimulation leads for use with its Precision Plus Spinal Cor...

Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of two spinal cord stimulation leads for use with its Precision Plus Spinal Cor...

Belo Sun Mining Corp. (the "Company" or "Belo Sun") is pleased to announce that it has granted a total of 1,968,000 options under the share option plan of the Company to...

Boston Scientific Corporation is scheduled to participate in the BMO Capital Markets Healthcare Conference on August 5th in New York.

Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ Stent System, its fourth-generation intracranial aneurysm stent system d...

Boston Scientific Corporation today announced financial results for the second quarter ended June 30, 2010, as well as guidance for net sales and earnings per share for...